作者:Houston Adam R , Beall Reed F , Attaran Amir
来源:[J].Journal of pharmaceutical policy and practice, 2016, Vol.9, pp.15PubMed
摘要:Exorbitant price increases for critical off-patent medicines have received considerable media attention in recent months, leading to an investigation by the U.S. Senate. However, much of this attention has focused upon the companies that initiated the price increases, all of whom...
作者:Kaplan Warren A , Beall Reed F
来源:[J].Journal of pharmaceutical policy and practice, 2017, Vol.10, pp.3PubMed
摘要:Lack of access to insulin and poor health outcomes are issues for both low and high income countries. This has been accompanied by a shift from relatively inexpensive human insulin to its more expensive analogs, marketed by three to four main global players. Nonetheless, patent-b...
作者:Beall Reed F , Schwalm Jon-David R ...
来源:[J].Journal of translational medicine(IF 3.459), 2016, Vol.14 (1), pp.242PubMed
摘要:The Wellcome Trust, the World Health Organization, and cardiologists have advocated for the idea of a "polypill" containing multiple cardiovascular drugs to be co-formulated into a single pill for over a decade. Some cardiologists have asserted that the drugs commonly considered ...


资源合作, +86-10-82896619   意见反馈